As of May 25
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Inspyr Therapeutics Inc have a median target of 60.00, with a high estimate of 60.00 and a low estimate of 60.00. The median estimate represents a +11,499.36% increase from the last price of 0.52.
The current consensus among 1 polled investment analysts is to Buy stock in Inspyr Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.